Cytotoxic T lymphocyte immunotherapeutic targeted at the HIV gag gene and transduced with the HyTK retrovirus data

TGEN (Seattle) completed a Phase I trial in six HIV-positive patients. The study demonstrated safety and cell engraftment in vivo, TGEN said. The main side effect was minor fever. ...